Reference data : LOINC code

Filter


Clear filter

Results
104,672 results found
Loinc Number Component Property System Time aspect ScaleType MethodType Relat_nms loincStatus Long Common name answerList chngType DefinitionDescription dtLastCh exactCmspy exampleUnits exmplAnswers externalCopyrightNotice formula hl7FieldSubfieldId InpcPercentage ipccUnits loincClass loincFinal loincNum mapTo methodTyp molarMass naaccrId orderObs panelElements reference scope setRoot shortName source surveyQuestSrc surveyQuestText unitsRequired acssym relatedNames2 VersionLastChanged VersionFirstRelease ValidHL7AttachmentRequest PanelType AssociatedObservations EXTERNAL_COPYRIGHT_LINK HL7_ATTACHMENT_STRUCTURE CONSUMER_NAME EXAMPLE_UCUM_UNITS STATUS_REASON STATUS_TEXT CHANGE_REASON_PUBLIC COMMON_TEST_RANK COMMON_ORDER_RANK
105030-1 Bacterial Carbapenem resistance blaOXA-244 gene PrThr Isolate/Specimen Pt Ord Molgen   ACTIVE Bacterial Carbapenem resistance blaOXA-244 gene [Presence] by Molecular method   ADD DefinitionDescription                   ABXBACT   105030-1   Molgen     Both       0 blaOXA-244 Islt/Spm Ql       N   ANTIBIOTIC SUSCEPTIBILITIES; Bact; CPR; Islt; Islt/Spm; Isol; Molecular genetics; Ordinal; PCR; Point in time; PR; QL; Qual; Qualitative; Random; Resist; Resistanc; Resistant; Resistent; Screen; Spec 2.78 2.78                       0
105031-9 Bacterial Carbapenem resistance blaOXA-58 gene PrThr Isolate/Specimen Pt Ord Molgen   ACTIVE Bacterial Carbapenem resistance blaOXA-58 gene [Presence] by Molecular method   ADD DefinitionDescription                   ABXBACT   105031-9   Molgen     Order       0 blaOXA-58 Islt/Spm Ql       N   ANTIBIOTIC SUSCEPTIBILITIES; Bact; Carbapenem res blaOXA-58; CPR; Islt; Islt/Spm; Isol; Molecular genetics; Ordinal; PCR; Point in time; PR; QL; Qual; Qualitative; Random; Resist; Resistanc; Resistant; Resistent; Screen; Spec 2.78 2.78                       0
105032-7 Bacterial Carbapenem resistance blaOXA-72 gene PrThr Isolate/Specimen Pt Ord Molgen   ACTIVE Bacterial Carbapenem resistance blaOXA-72 gene [Presence] by Molecular method   ADD DefinitionDescription                   ABXBACT   105032-7   Molgen     Both       0 blaOXA-72 Islt/Spm Ql       N   ANTIBIOTIC SUSCEPTIBILITIES; Bact; CPR; Islt; Islt/Spm; Isol; Molecular genetics; Ordinal; PCR; Point in time; PR; QL; Qual; Qualitative; Random; Resist; Resistanc; Resistant; Resistent; Screen; Spec 2.78 2.78                       0
105033-5 Bacterial Carbapenem resistance ISAba1 upstream blaOXA-51 gene PrThr Isolate/Specimen Pt Ord Molgen   ACTIVE Bacterial Carbapenem resistance ISAba1 upstream blaOXA-51 gene [Presence] by Molecular method   ADD DefinitionDescription                   ABXBACT   105033-5   Molgen     Both       0 ISAba1 upstream blaOXA-51 Islt/Spm Ql       N   ANTIBIOTIC SUSCEPTIBILITIES; Bact; CPR; Islt; Islt/Spm; Isol; Molecular genetics; Ordinal; PCR; Point in time; PR; QL; Qual; Qualitative; Random; Resist; Resistanc; Resistant; Resistent; Screen; Spec 2.78 2.78                       0
105034-3 Bacterial Carbapenem resistance blaVIM-1 gene PrThr Isolate/Specimen Pt Ord Molgen   ACTIVE Bacterial Carbapenem resistance blaVIM-1 gene [Presence] by Molecular method   ADD DefinitionDescription                   ABXBACT   105034-3   Molgen     Order       0 blaVIM-1 Islt/Spm Ql       N   ANTIBIOTIC SUSCEPTIBILITIES; Bact; CPR; i; Islt; Islt/Spm; Isol; Molecular genetics; Ordinal; PCR; Point in time; PR; QL; Qual; Qualitative; Random; Resist; Resistanc; Resistant; Resistent; Screen; Spec 2.78 2.78                       0
105035-0 Bacterial Carbapenem resistance blaVIM-2 gene PrThr Isolate/Specimen Pt Ord Molgen   ACTIVE Bacterial Carbapenem resistance blaVIM-2 gene [Presence] by Molecular method   ADD DefinitionDescription                   ABXBACT   105035-0   Molgen     Both       0 blaVIM-2 Islt/Spm Ql       N   ANTIBIOTIC SUSCEPTIBILITIES; Bact; CPR; II; Islt; Islt/Spm; Isol; Molecular genetics; Ordinal; PCR; Point in time; PR; QL; Qual; Qualitative; Random; Resist; Resistanc; Resistant; Resistent; Screen; Spec 2.78 2.78                       0
105036-8 Bacterial Carbapenem resistance blaVIM-4 gene PrThr Isolate/Specimen Pt Ord Molgen   ACTIVE Bacterial Carbapenem resistance blaVIM-4 gene [Presence] by Molecular method   ADD DefinitionDescription                   ABXBACT   105036-8   Molgen     Both       0 blaVIM-4 Islt/Spm Ql       N   ANTIBIOTIC SUSCEPTIBILITIES; Bact; CPR; Islt; Islt/Spm; Isol; Molecular genetics; Ordinal; PCR; Point in time; PR; QL; Qual; Qualitative; Random; Resist; Resistanc; Resistant; Resistent; Screen; Spec 2.78 2.78                       0
105037-6 OXA-23 carbapenemase PrThr Isolate/Specimen Pt Ord IA.rapid   ACTIVE OXA-23 carbapenemase [Presence] by Rapid immunoassay   ADD DefinitionDescription                   ABXBACT   105037-6   IA.rapid     Both       0 OXA-23 Islt/Spm Ql IA.rapid       N   ANTIBIOTIC SUSCEPTIBILITIES; carbapenem-resistant Klebsiella pneumoniae; CRE; CRKP; EIA; ELFA; ELISA; Enzyme immunoassay; Hodge test; IAA; Islt; Islt/Spm; Isol; MEIA; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spec; SUDS 2.78 2.78                       0
105038-4 OXA-40+58 carbapenemase PrThr Isolate/Specimen Pt Ord IA.rapid   ACTIVE OXA-40 and OXA-58 carbapenemase [Presence] by Rapid immunoassay   NAM DefinitionDescription                   ABXBACT   105038-4   IA.rapid     Both       0 OXA-40/58 carba Islt/Spm Ql IA.rapid       N   ANTIBIOTIC SUSCEPTIBILITIES; carbapenem-resistant Klebsiella pneumoniae; CRE; CRKP; EIA; ELFA; ELISA; Enzyme immunoassay; Hodge test; IAA; Islt; Islt/Spm; Isol; MEIA; Ordinal; OXA-40 & 58 carbapenemase; OXA-40/58; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spec; SUDS 2.79 2.78                     Release 2.79: COMPONENT: Correction to the component; 0
105039-2 Date of expiration Date {Setting} Pt Qn     ACTIVE Date of expiration   ADD DefinitionDescription     MMDDYY             DOC.ADMIN   105039-2         Observation       0 Exp date       N   ADMIN; DOC.ADMIN; Exp; Exp date; Point in time; QNT; Quan; Quant; Quantitative; Random 2.78 2.78               {mm/dd/yyyy}       0
10504-9 Myelin basic protein Ag PrThr Tiss Pt Ord Immune stain   ACTIVE Myelin basic protein Ag [Presence] in Tissue by Immune stain   MAJ DefinitionDescription                   PATH   10504-9   Immune stain     Both       0 MBP Ag Tiss Ql ImStn           Antigen; Antigens; IHC; Imm; Immunohistochemical stain; Immunostain; ImStn; Imun; Imune; MBP; Ordinal; Pathology; Point in time; PR; Prot; QL; Qual; Qualitative; Random; Screen; St; Stains; Stn; Tissue; Tissue, unspecified 2.56 1.0i                     The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. 0
105040-0 Hemoglobin MCnc BldMV Pt Qn Calculated   ACTIVE Hemoglobin [Mass/volume] in Mixed venous blood by calculation   ADD DefinitionDescription     g/dL             HEM/BC   105040-0   Calculated     Observation       0 Hgb BldMV Calc-mCnc       N   Bld mixed venous; Blood - mixed venous; Calc; Calculation; Haemoglobin; Hb; HEMATOLOGY/CELL COUNTS; Hgb; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random 2.78 2.78               g/dL       0
105041-8 Risankizumab MCnc Ser/Plas Pt Qn     ACTIVE Risankizumab [Mass/volume] in Serum or Plasma   ADD DefinitionDescription     mg/dL             DRUG/TOX   105041-8         Both       0 Risankizumab SerPl-mCnc       N   DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR 2.78 2.78               mg/dL       0
105042-6 Ramsay sedation scale - ^Patient Pt - Reported.RSS   ACTIVE Ramsay sedation scale [Reported.RSS]   ADD DefinitionDescription                   PANEL.SURVEY.RSS   105042-6   Reported.RSS     Order       0         N   Pan; Panel; PANEL.SURVEY.RSS; Panl; Pnl; Point in time; Random; Survey; SURVEY.RSS 2.78 2.78   Panel                   0
105043-4 Sedation level Find ^Patient Pt Ord Reported.RSS   ACTIVE Sedation level [Reported.RSS]   ADD DefinitionDescription                   SURVEY.RSS   105043-4   Reported.RSS     Observation       0         N   Finding; Findings; Levels; Levl; LV; LVL; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Sed lvl; Survey; SURVEY.RSS 2.78 2.78                       0
105044-2 Ramsay sedation scale total score Score ^Patient Pt Qn Reported.RSS   ACTIVE Ramsay sedation scale total score [Reported.RSS]   ADD DefinitionDescription     score             SURVEY.RSS   105044-2   Reported.RSS     Observation       0         N   Point in time; QNT; Quan; Quant; Quantitative; Random; RSS total score; Scale; Survey; SURVEY.RSS; Tot; Totl 2.78 2.78               {score}       0
105045-9 Electronic cigarette status Find ^Patient Pt Nom     ACTIVE Electronic cigarette status   ADD DefinitionDescription                   CLIN   105045-9         Both       0 E cig status       N   CLIN; E cig status; Electronic nicotine delivery system; Finding; Findings; Hookah; Nominal; Point in time; Random; Smoke; Smokes; Smoking; Tobacco; Vaping status 2.78 2.78                       0
105046-7 Coagulation surface induced.factor substitution^2H post incubation after 1:1 addition of normal plasma TRto PPP^Control Pt Qn Coag   DISCOURAGED aPTT.factor substitution [Time Ratio] in Control Platelet poor plasma by Coagulation assay --2H post incubation with 1:1 normal plasma   MIN DefinitionDescription     ratio             COAG   105046-7   Coag     Both       0 aPTT 2h p 1:1 NP PPP Cont       N   120 min; 120 minutes; 120min; 2 hours; 2h p 1:1 NP; 2h p Inc; Activated partial thromboplastin time; After; aPTT; aPTT correction study; Clot; Clottable; Coag; Coagulation assay; Contrl; Control; Fac; Fact; i; Little(A)PTT; Mixing studies; Normal; Partial Thromboplastin Time; Plas; Platelet poor plasma; Point in time; PST; PTT; QNT; Quan; Quant; Quantitative; Random; Surf; Tilt tube; Time ratio 2.79 2.78       AssociatedObservations EXTERNAL_COPYRIGHT_LINK HL7_ATTACHMENT_STRUCTURE CONSUMER_NAME EXAMPLE_UCUM_UNITS STATUS_REASON STATUS_TEXT CHANGE_REASON_PUBLIC COMMON_TEST_RANK COMMON_ORDER_RANK
105047-5 Clostridioides difficile presence and susceptibility Find XXX Pt Doc Organism specific culture   ACTIVE Clostridioides difficile presence and susceptibility in Specimen Document by Organism specific culture   ADD DefinitionDescription                   MICRO   105047-5   Organism specific culture     Both       0 C. diff presence & sus Org culture       N   C diff; C difficile; C&S; C. difficile presence and susceptibility; Clostridium difficile; Cult; Cultures; Document; Finding; Findings; Microbiology; Misc; Miscellaneous; Other; Point in time; Random; Spec; Sus; Susc; Suscept; Susceptibilities; Susceptibilty; To be specified in another part of the message; Unspecified 2.78 2.78                       0
105048-3 Coagulation surface induced.factor substitution^immediately after addition of normal plasma TRto PPP^Control Pt Qn Coag   DISCOURAGED aPTT.factor substitution [Time Ratio] in Control Platelet poor plasma by Coagulation assay --immediately after addition of normal plasma   MIN DefinitionDescription     ratio             COAG   105048-3   Coag     Both       0 aPTT imm NP PPP Cont       N   Activated partial thromboplastin time; aPTT; aPTT correction study; Clot; Clottable; Coag; Coagulation assay; Contrl; Control; Fac; Fact; imm NP; Immediatedly after 1:1 addition of; Little(A)PTT; Mixing studies; Normal; Partial Thromboplastin Time; Plas; Platelet poor plasma; Point in time; PTT; QNT; Quan; Quant; Quantitative; Random; Surf; Tilt tube; Time ratio 2.79 2.78       AssociatedObservations EXTERNAL_COPYRIGHT_LINK HL7_ATTACHMENT_STRUCTURE CONSUMER_NAME EXAMPLE_UCUM_UNITS STATUS_REASON STATUS_TEXT CHANGE_REASON_PUBLIC COMMON_TEST_RANK COMMON_ORDER_RANK
105049-1 Coagulation tissue factor induced.factor substitution^2H post incubation after 1:1 addition of normal plasma TRto PPP^Control Pt Qn Coag   DISCOURAGED Prothrombin time (PT) factor substitution [Time Ratio] in Control Platelet poor plasma by Coagulation assay --2H post incubation with 1:1 normal plasma   MIN DefinitionDescription     ratio             COAG   105049-1   Coag     Both       0 PT 2h p 1:1 NP PPP Cont       N   120 min; 120 minutes; 120min; 2 hours; 2h p 1:1 NP; 2h p Inc; After; Clot; Clottable; Coag; Coagulation assay; Contrl; Control; Fac; Fact; i; Mixing studies; Normal; Plas; Platelet poor plasma; Point in time; Pro time; Prothrombin time; Protime; PST; PT; PT correction study; PT immediate mix; PT incubated mix; QNT; Quan; Quant; Quantitative; Random; Tilt tube; Time ratio 2.79 2.78       AssociatedObservations EXTERNAL_COPYRIGHT_LINK HL7_ATTACHMENT_STRUCTURE CONSUMER_NAME EXAMPLE_UCUM_UNITS STATUS_REASON STATUS_TEXT CHANGE_REASON_PUBLIC COMMON_TEST_RANK COMMON_ORDER_RANK
10505-6 Myoglobin Ag PrThr Tiss Pt Ord Immune stain   ACTIVE Myoglobin Ag [Presence] in Tissue by Immune stain   MIN DefinitionDescription                   PATH   10505-6   Immune stain     Both       0 Myoglobin Ag Tiss Ql ImStn           Antigen; Antigens; IHC; Imm; Immunohistochemical stain; Immunostain; ImStn; Imun; Imune; Mb; Myog; Ordinal; PATHOLOGY; Point in time; PR; QL; Qual; Qualitative; Random; Screen; St; Stains; Stn; Tissue; Tissue, unspecified 2.73 1.0i                     The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. 0
105050-9 Xanthochromia PrThr XXX Pt Ord     ACTIVE Xanthochromia [Presence] of Specimen Qualitative   ADD DefinitionDescription                   SPEC   105050-9         Both       0 Xanthochromia Spec Ql       N   Misc; Miscellaneous; Ordinal; Other; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SPEC; To be specified in another part of the message; Unspecified; Xanthchromia; Xanthochromic 2.78 2.78                       0
105051-7 Bacteria Naric Urine sed Pt Qn Microscopy   ACTIVE Bacteria [#/area] in Urine sediment by Microscopy   ADD DefinitionDescription     /[HPF]             MICRO   105051-7   Microscopy     Both       0 Bacteria UrnS Micro-#/area       N   #/area; Bact; Micro; Microbiology; Micros; Microscopic; Number areic; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urine sediment; Urn; UrnS 2.78 2.78               /[HPF]       0
105052-5 Bacteria PrThr Urine sed Pt Ord Microscopy   ACTIVE Bacteria [Presence] in Urine sediment by Microscopy   ADD DefinitionDescription                   MICRO   105052-5   Microscopy     Both       0 Bacteria UrnS Ql Micro       N   Bact; Micro; Microbiology; Micros; Microscopic; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; UA; UR; Urine sediment; Urn; UrnS 2.78 2.78                       0
104,672 results found